Systematic Literature Review of the Efficacy of Available Interventions for Patients with Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) Who Have Previously Been Treated with >= 2 Lines of Tyrosine Kinase Inhibitors (TKIs)-论文-万方医学网

首页> > Systematic Literature Review of the Efficacy of Available Interventions for Patients with Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) Who Have Previously Been Treated with >= 2 Lines of Tyrosine Kinase Inhibitors (TKIs)

Systematic Literature Review of the Efficacy of Available Interventions for Patients with Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) Who Have Previously Been Treated with >= 2 Lines of Tyrosine Kinase Inhibitors (TKIs)

导出原文传递

翻译打印收藏纠错

第一作者： Atallah, Ehab

作者： Atallah, Ehab ^[1] ; Patwardhan, Pallavi ^[2] ; Mojebi, Ali ^[3] ; Maegawa, Rodrigo ^[4] ; Wu, Ping ^[5] ; Thakur, Deepika ; Keeping, Sam ; Viana, Ricardo

作者单位： Med Coll Wisconsin, Milwaukee, WI 53226 USA ^[1] Novartis Pharmaceut, E Hanover, NJ USA ^[2] PRECISIONheor, New York, NY USA ^[3] Novartis Healthcare Pvt Ltd, Chennai, Tamil Nadu, India ^[4] Novartis Pharma AG, Basel, Switzerland ^[5]

关键词 chronic myeloid leukemia chronic myelogenous leukemia tyrosine kinase inhibitor systematic review literature review

发布时间 2022-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Systematic Literature Review of the Efficacy of Available Interventions for Patients with Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) Who Have Previously Been Treated with >= 2 Lines of Tyrosine Kinase Inhibitors (TKIs)

相似文献

同项目论文

相关期刊

检索历史 清除

Systematic Literature Review of the Efficacy of Available Interventions for Patients with Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) Who Have Previously Been Treated with >= 2 Lines of Tyrosine Kinase Inhibitors (TKIs)

相似文献

同项目论文

相关期刊

检索历史清除